Elderberry cyanidin glycosides inhibit viral neuraminidase the same mechanism as oseltamivir (Tamiflu).

That's a specific, defined, anti-viral target. But the industry markets elderberry as generic "immune support" because regulators won't allow anti-viral claims on a food supplement.

The mechanism is there. The IP is there. The claim structure isn't.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/23748498/

https://pubmed.ncbi.nlm.nih.gov/19682714/

https://pubmed.ncbi.nlm.nih.gov/29199545/

Intravenous silibinin (Legalon SIL) is the standard of care for Amanita phalloides mushroom poisoning in European hospitals.

Milk thistle is one of the only botanical ingredients that has crossed the line from supplement to emergency medicine.

That level of clinical validation is almost unique in the natural products space.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/22352731/

https://pubmed.ncbi.nlm.nih.gov/6862461/

https://pubmed.ncbi.nlm.nih.gov/23330770/

Silymarin contains two isomers of silybin (A and B) with different 3D configurations and different biological activity.

No commercial standardization distinguishes between them.

A product optimized for the more potent isomer on metabolic targets would be a genuinely novel ingredient from a plant used for 2,000 years.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/22224281/

https://pubmed.ncbi.nlm.nih.gov/34360650/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6150307/

Silymarin has been "the liver ingredient" for 2,000 years.

But silybin (the most active flavonolignan in silymarin) activates IRS-1 phosphorylation and GLUT4 translocation core mechanisms of insulin sensitivity and glucose uptake.

With 25% of the global population having NAFLD/MAFLD, the metabolic health repositioning of silymarin could be worth more than its entire current liver health market.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/25760026/

https://pubmed.ncbi.nlm.nih.gov/24036369/

https://pubmed.ncbi.nlm.nih.gov/32950646/

Grape seed extract comes from pomace ,the leftover skins, seeds, and stems from winemaking.

Bordeaux alone produces enough pomace annually to supply the global OPC market many times over.

It's one of the few botanical ingredients where the supply chain is up-cycled agricultural waste.

And yet it's not marketed that way.

Publications of interest:

https://pmc.ncbi.nlm.nih.gov/articles/PMC11462180/

https://pmc.ncbi.nlm.nih.gov/articles/PMC7447760/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6222734/

Grape seed OPCs (oligomeric proanthocyanidins) come in dimers, trimers, and higher polymers.

Dimers and trimers are absorbed intact and have direct vascular effects (NO pathway). Higher polymers are fermented by gut bacteria into phenylvalerolactones with their own bioactivity.

The entire grape seed market standardizes on "% total polyphenols" ignoring that the chain length determines whether the compound acts in the bloodstream or the gut.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/11813991/

https://pubmed.ncbi.nlm.nih.gov/11053514/

https://pmc.ncbi.nlm.nih.gov/articles/PMC9854439/

Most green tea extract supplements say "antioxidant."

The actual mechanism that drives weight management results is COMT inhibition (extending norepinephrine activity) + AMPK activation (thermogenesis).

Those are pharmacological actions, not "antioxidant properties."

Selling EGCG as an antioxidant is like selling aspirin as a headache remedy and ignoring its cardiovascular mechanism.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/30524290/

https://pubmed.ncbi.nlm.nih.gov/18197555/

https://pubmed.ncbi.nlm.nih.gov/28137482/

L-theanine ,the amino acid that promotes alpha brain wave activity, is naturally co-present with EGCG in green tea.

The calming focus of tea (vs. the jitteriness of coffee) is an L-theanine effect, not a catechin effect. Yet the entire green tea extract market is standardized on catechins/EGCG.

The L-theanine is stripped out during most extraction processes. You extract the antioxidant but discard the nootropic.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/18296328/

https://pubmed.ncbi.nlm.nih.gov/18841456/

https://pubmed.ncbi.nlm.nih.gov/23883567/

EFSA set an 800mg/day upper limit for EGCG after reviewing hepatotoxicity cases.

Some concentrated supplements deliver 400-500mg per capsule. Two capsules and you're above the safety limit. The same ingredient with 10,000+ studies proving benefit also has a documented signal for liver damage at doses that many products comfortably deliver.

The therapeutic window is narrower than the market acknowledges.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/32625874/

https://pmc.ncbi.nlm.nih.gov/articles/PMC7009618/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10060436/

Salidroside modulates HIF-1alpha (hypoxia-inducible factor).

This is the master switch for oxygen sensing in cells. No other adaptogen directly targets this pathway.

That's why rhodiola has unique data on altitude performance, fatigue under hypoxic conditions, and VO2max enhancement that ashwagandha and ginseng don't match.

Publications of interest:

https://pubmed.ncbi.nlm.nih.gov/34739769/

https://pubmed.ncbi.nlm.nih.gov/22309741/

https://pmc.ncbi.nlm.nih.gov/articles/PMC11610317/